Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
复制标题
DOI:
10.1007/s00520-017-4013-0
复制
发表时间:
2018-04
期刊:
影响因子:
--
通讯作者:
Mustian KM
中科院分区:
文献类型:
--
作者:
Kleckner IR;Kamen C;Gewandter JS;Mohile NA;Heckler CE;Culakova E;Fung C;Janelsins MC;Asare M;Lin PJ;Reddy PS;Giguere J;Berenberg J;Kesler SR;Mustian KM
Over half of all cancer patients receiving taxane-, platinum-, or vinca alkaloid-based chemotherapy experience chemotherapy-induced peripheral neuropathy (CIPN), which includes numbness, tingling, pain, cold sensitivity, and motor impairment in the hands and feet. CIPN is a dose-limiting toxicity, potentially increasing mortality. There are no FDA-approved drugs to treat CIPN, and behavioral interventions such as exercise are promising yet understudied. This secondary analysis of our nationwide phase III randomized controlled trial of exercise for fatigue examines (1) effects of exercise on CIPN symptoms, (2) factors that predict CIPN symptoms, and (3) factors that moderate effects of exercise on CIPN symptoms. Cancer patients (N=355, 56±11 years, 93% female, 79% breast cancer) receiving taxane-, platinum-, or vinca alkaloid-based chemotherapy were randomized to chemotherapy or chemotherapy plus Exercise for Cancer Patients (EXCAP©®). EXCAP is a standardized, individualized, moderate-intensity, home-based, six-week progressive walking and resistance exercise program. Patients reported CIPN symptoms of numbness and tingling and hot/coldness in hands/feet (0–10 scales) pre- and post-intervention. We explored baseline neuropathy, sex, age, body mass index, cancer stage, and cancer type as possible factors associated with CIPN symptoms and exercise effectiveness. Exercise reduced CIPN symptoms of hot/coldness in hands/feet (−0.46 units, p=0.045) and numbness and tingling (−0.42 units, p=0.061) compared to the control. Exercise reduced CIPN symptoms more for patients who were older (p=0.086), male (p=0.028), or had breast cancer (p=0.076). Exercise appears to reduce CIPN symptoms in patients receiving taxane-, platinum-, or vinca alkaloid-based chemotherapy. Clinicians should consider prescribing exercise for these patients.
登录
查看更多内容
影响因子:
3.1
作者:
Majithia, Neil;Temkin, Sarah M.;Ruddy, Kathryn J.;Beutler, Andreas S.;Hershman, Dawn L.;Loprinzi, Charles L.
通讯作者:
Loprinzi, Charles L.
影响因子:
8.8
作者:
Courneya, K. S.;McKenzie, D. C.;Mackey, J. R.;Gelmon, K.;Friedenreich, C. M.;Yasui, Y.;Reid, R. D.;Vallerand, J. R.;Adams, S. C.;Proulx, C.;Dolan, L. B.;Wooding, E.;Segal, R. J.
通讯作者:
Segal, R. J.
影响因子:
3.1
作者:
Brouwers, Elke E. M.;Huitema, Alwin D. R.;Schellens, Jan H. M.
通讯作者:
Schellens, Jan H. M.
影响因子:
4.8
作者:
Huang P;Fang R;Li BY;Chen SD
通讯作者:
Chen SD
影响因子:
13.9
作者:
Costigan M;Scholz J;Woolf CJ
通讯作者:
Woolf CJ